LivFul Inc.

SEC filing

Pharmaceuticals · Temple, TX

Form D on EDGAR

Amount raised$250Ksold at filing

Total offering$26M$25.8M still open

Investors in the raise2count reported to the SEC

FiledDec 16, 2025first sale Dec 8, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Hogan BasseyExecutive Officer, Director

Matt ElsberryExecutive Officer, Director

Yaw NsarkohDirector

John ManwellExecutive Officer, Director

Kris MaynardDirector

Michael NormanExecutive Officer, Director

Andrew BarlowDirector

Carl ThongDirector

Executive officers, directors and promoters as listed on the Form D.